Spectrumedics

Spectrumedics Medical Technology (Shanghai) Co., Ltd. was founded in March 2019 by a returned overseas Chinese who has深耕ed in the cardiovascular device field for many years. It is a medical technology enterprise focusing on combining active technology with cardiovascular minimally invasive interventional therapy. Its first product launched is the Sonico intravascular shock wave balloon catheter system, which was independently developed by the company and has been granted patent authorization. This system mainly targets the treatment of arterial vascular calcification. The core team members have professional backgrounds covering multiple disciplines such as electrical, mechanical, acoustics, bioengineering, and biomaterials. They have in-depth cooperation with well-known medical experts both domestically and internationally and also have an overseas research and development team. The team members are young and energetic, possessing innovative awareness and the courage to meet challenges.